Regucalcin (RGN/SMP30) alters agonist- and thapsigargin- induced cytosolic [Ca2+] transients in cells by increasing SERCA Ca(2+)ATPase levels

P Lai, Nga Yip, Francesco Michelangeli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Regucalcin (RGN), also reported as senescence marker protein-30 (SMP30), plays a role in Ca2+ homeostasis by modulating a number of Ca2+-dependent proteins. RGN also plays a cyto-protective role and its decrease is linked to age-related diseases and cell death. This study shows that RGN reduces agonist (histamine)-induced Ca2+ transients in RGN(+) transfected COS-7 cells (RGN(+)) and also increases their Ca2+ storage capacity. These observations are explained by RGN(+) cells having increased mRNA and protein expression levels of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). Therefore down-regulation of RGN expression may contribute to characteristics of age-dependent Ca2+ homeostasis dis-regulation, by decreasing SERCA levels. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Original languageEnglish
Pages (from-to)2291-2294
Number of pages4
JournalFEBS Letters
Volume585
Issue number14
DOIs
Publication statusPublished - 1 Jul 2011

Keywords

  • Calcium homeostasis
  • Regucalcin
  • Sarco/endo-plasmic reticulum Ca2+-ATPase
  • Aging
  • Senescence marker protein-30

Fingerprint

Dive into the research topics of 'Regucalcin (RGN/SMP30) alters agonist- and thapsigargin- induced cytosolic [Ca2+] transients in cells by increasing SERCA Ca(2+)ATPase levels'. Together they form a unique fingerprint.

Cite this